Filter
4011
Filtered Results: 4011
Text search:
drug
situation
Featured
Recommendations
356
New Publications
1118
Language
Document type
No document type
2504
Studies & Reports
532
Guidelines
532
Manuals
176
Strategic & Response Plan
126
Training Material
51
Fact sheets
47
Situation Updates
25
Brochures
6
Infographics
6
Resource Platforms
5
App
1
Countries / Regions
India
246
Kenya
138
Global
110
Ethiopia
101
Western and Central Europe
95
Uganda
93
Nigeria
92
South Africa
90
Sierra Leone
79
Liberia
78
Nepal
76
Tanzania
76
Myanmar / Burma
71
Malawi
66
Bangladesh
60
Latin America and the Carribbean
59
Ghana
58
Zambia
55
Africa
50
Rwanda
47
Ukraine
42
Namibia
38
Philippines
36
Eastern Europe
36
Asia
29
South–East Asia Region
29
Zimbabwe
28
Cambodia
28
Congo, Democratic Republic of
27
Germany
24
Lesotho
23
Syria
23
Senegal
23
Colombia
22
Botswana
19
Indonesia
18
Burkina Faso
16
Mozambique
16
Haiti
15
Russia
14
Cameroon
13
Venezuela
13
Brazil
13
South Sudan
12
Eswatini/ Swaziland
12
Middle East and North Africa
11
Eastern Europe and Central Asia
11
Thailand
10
Albania
10
Peru
10
USA
10
Pakistan
10
Tajikistan
9
Guinea
9
Argentina
9
Georgia
9
China
8
Chile
8
Laos
7
West and Central Africa
7
Paraguay
7
Vietnam
7
Benin
6
Afghanistan
6
East and Southern Africa
6
Moldova
6
Sudan
6
North Macedonia
5
El Salvador
5
Western Pacific Region
5
Bolivia
5
Sri Lanka
5
Iraq
5
Mexico
4
Turkey
4
Jordan
4
North America
4
Jamaica
4
Lebanon
4
Yemen
4
Central African Republic
4
Mali
4
Bhutan
4
Madagascar
4
Switzerland
3
Timor Leste/ East Timor
3
Iran
3
Fiji
3
Kyrgyzstan
3
Morocco
3
Armenia
3
United Kingdom
3
Spain
3
Papua New Guinea
3
Somalia
3
Serbia
2
Kazakhstan
2
Estonia
2
Uzbekistan
2
Hungary
2
Gabon
2
Uruguay
2
France
2
Portugal
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Palestine
2
Poland
2
Libya
2
Ecuador
2
North Korea
1
Gambia
1
Canada
1
Congo-Brazzaville
1
Niger
1
Austria
1
Qatar
1
Bulgaria
1
Italy
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belarus
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Angola
1
Authors & Publishers
Publication Years
Category
Countries
1655
Clinical Guidelines
336
Public Health
193
Women & Child Health
160
Key Resources
125
Capacity Building
62
Pharmacy & Technologies
35
Annual Report MEDBOX
1
Toolboxes
Mental Health
420
HIV
394
TB
353
AMR
206
COVID-19
205
NTDs
136
Pharmacy
95
Rapid Response
84
Caregiver
77
Ebola & Marburg
68
Refugee
60
Conflict
60
NCDs
52
Disability
49
Planetary Health
45
Global Health Education
44
Natural Hazards
20
Polio
20
Health Financing Toolbox
19
Zika
18
Specific Hazards
15
Cholera
15
Social Ethics
14
Malaria
11
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
The Bolivarian Republic of Venezuela has been facing a sociopolitical and economic situation that has negatively impacted social and health indicators. There have been intensified population movements both within the country and to other countries, particularly to Argentina, Brazil, Chile, Colombia,...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Regulation of the Minister of Health of the Republic of Indonesia on Impact Reduction for Injecting Narcotics Drug Users
NAPZA : Narkotika, Psikotropika dan Zat Adiktif Lainnya (Narcotics, Psychotropic and Other Addictive Substances)
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
BMC Infectious Diseases (2019) 19:832
Intestinal schistosomiasis is highly endemic in Tanzania and mass drug administration (MDA) using
praziquantel is the mainstay of the control program. However, the MDA program covers only school aged children
and does not include neither adult individuals nor...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Policy Note #2: Myanmar Health Systems in Transition Policy Notes Series
Myanmar is a country in which people’s access to health services is determined more by where they live than their need for care – a situation that is fundamentally inequitable. The challenge is to reduce levels of ineq...
Myanmar is a country in which people’s access to health services is determined more by where they live than their need for care – a situation that is fundamentally inequitable. The challenge is to reduce levels of ineq...
This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for attaining the targets. The 2010 baseline estimates on N...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
hese are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region, the guidelines were developed for use by medical personnel who treat severe malaria pat...
Following the high-level meeting of the UN General Assembly on antimicrobial resistance held in September 2016 which called for national, regional and international political commitment to address the issue, member countries agreed on the importance of moving forward to develop national action plans...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
